Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 713 (USA) (Dr. Kowalski)
· consented 2013-05-31
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-30 (study day 31.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate DELIRIUM — outcome: RECOVERED/RESOLVED; onset 2013-07-01 (study day 32.0); relationship: POSSIBLE; serious criteria: hospitalization
mild
assessed
2026-08-18
Mild RASH PRURITIC — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-21 (study day 22.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild RASH PRURITIC — outcome: RECOVERED/RESOLVED; onset 2013-06-21 (study day 22.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.